Itrizole and white blood cell count decreased Patient Reports February 13, 2012

Itrizole Side Effects Report #5498025-0
Itrizole side effect was reported by a Physician from JAPAN on Oct 15, 2007. Male patient, child 9 years of age, was diagnosed with tinea capitis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: eosinophilia, white blood cell count decreased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4642664-3
Itrizole side effect was reported by a Physician from on Apr 07, 2005. Male patient, 45 years of age, was diagnosed with prophylaxis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: constipation , neurotoxicity, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, RITUXIMAB, ETOPOSIDE, DOXORUBICIN HYDROCHLORIDE, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

Itrizole Side Effects Report #5594428-4
Itrizole side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma , purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.

Itrizole Side Effects Report #5605650-2
Itrizole side effect was reported by a Physician from JAPAN on Jan 21, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma , purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.


Itrizole Side Effects Report #4714273-9
Itrizole side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 45 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, oedema peripheral, white blood cell count decreased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4883109-8
Itrizole side effect was reported by a Physician from JAPAN on Jan 11, 2006. Male patient, 56 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient recovered.

Itrizole Side Effects Report #4933993-4
Itrizole side effect was reported by a Physician from JAPAN on Feb 24, 2006. Male patient, 56 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA. Patient recovered.

Itrizole Side Effects Report #6055214-4
Itrizole side effect was reported by a Physician from JAPAN on Jan 21, 2009. Female patient, 78 years of age, weighting 97.00 lb, was diagnosed with bronchopulmonary aspergillosis, hypokalaemia, atrial fibrillation , interstitial lung disease and was treated with Itrizole. After drug was administered, patient experienced the following side effects: cellulitis , interstitial lung disease, pancytopenia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, COTRIM, TAKEPRON, WARFARIN, PREDONINE. Patient was hospitalized. Patient recovered.

Itrizole Side Effects Report #6104822-0
Itrizole side effect was reported by a Pharmacist from JAPAN on Mar 02, 2009. Male patient, 70 years of age, was treated with Itrizole. After drug was administered, patient experienced the following side effects: accidental overdose, faeces discoloured, renal impairment, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with HARNAL D, PARIET, MUCOSTA, MAGMITT, DIFLUCAN, CRAVIT. Patient was hospitalized. Patient recovered.


Itrizole Side Effects Report #4714274-0
Itrizole side effect was reported by a Pharmacist from JAPAN on June 28, 2005. Female patient, 64 years of age, was diagnosed with onychomycosis, constipation , breast cancer , paronychia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ANASTROZOLE, CEFPODOXIME PROXETIL. Patient recovered.

Itrizole Side Effects Report #4758568-1
Itrizole side effect was reported by a Physician from JAPAN on Aug 18, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.

Itrizole Side Effects Report #4791823-8
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.

Itrizole Side Effects Report #4791824-X
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.